Reports Q4 revenue $1.54B, consensus $1.54B. “Our Q4 performance was very strong, capping a stellar 2025,” said President and CEO Mark Tarr. “Our 2025 revenue increased 10.5% and Adjusted EBITDA grew 14.9%. During the year, we significantly increased our capacity, adding a total of 517 inpatient rehabilitation beds via eight new hospitals and the addition of 127 beds to existing hospitals. The need for the services we provide continues to grow as the U.S. population ages. We are uniquely positioned to meet this rising demand.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EHC:
- EHC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Encompass Health Appoints Cain Hayes to Board
- 3 Best Value Stocks with Over 30% Upside in 2026, According to Analysts
- 3 “Strong Buy” Value Stocks with Over 30% Upside, According to Analysts – 12/9/2025
